TY - JOUR
T1 - DNA methylation mediates the link between adversity and depressive symptoms
AU - Lussier, Alexandre A.
AU - Smith, Brooke J.
AU - Fisher, Jonah
AU - Luo, Mannan
AU - Cerutti, Janine
AU - Schneper, Lisa
AU - Smith, Trey
AU - Cecil, Charlotte A.M.
AU - Felix, Janine F.
AU - Mitchell, Colter
AU - Notterman, Daniel A.
AU - Ressler, Kerry J.
AU - Schaid, Daniel J.
AU - Simpkin, Andrew J.
AU - Suderman, Matthew J.
AU - Walton, Esther
AU - Smith, Andrew D.A.C.
AU - Dunn, Erin C.
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature America, Inc. 2024.
PY - 2024/12/2
Y1 - 2024/12/2
N2 - Experiences of childhood adversity can double the risk for depression. Although the mechanisms underlying this relationship remain unclear, DNA methylation (DNAm) has emerged as a potential pathway to explain the link between adversity and depression. We thus investigated whether epigenome-wide DNAm statistically mediates the association between childhood adversity and adolescent depressive symptoms. Specifically, we performed epigenome-wide mediation analyses to investigate the role of blood-based DNAm (age 7 years) in linking seven types of adversity (ages 0–7 years) to depressive symptoms (age 10.6 years). Primary analyses were conducted in the Avon Longitudinal Study of Parents and Children and replicated in the Future of Families and Child Wellbeing Study and Generation R Study. We identified 70 cytosine–guanine dinucleotides (CpGs) that mediated 10–73% of the correlation between adversity and depressive symptoms, with DNAm differences at 39 of these CpGs showing protective effects. Our findings suggest DNAm reflects a biological pathway linking childhood adversity to depression and a potential mechanism towards resilience.
AB - Experiences of childhood adversity can double the risk for depression. Although the mechanisms underlying this relationship remain unclear, DNA methylation (DNAm) has emerged as a potential pathway to explain the link between adversity and depression. We thus investigated whether epigenome-wide DNAm statistically mediates the association between childhood adversity and adolescent depressive symptoms. Specifically, we performed epigenome-wide mediation analyses to investigate the role of blood-based DNAm (age 7 years) in linking seven types of adversity (ages 0–7 years) to depressive symptoms (age 10.6 years). Primary analyses were conducted in the Avon Longitudinal Study of Parents and Children and replicated in the Future of Families and Child Wellbeing Study and Generation R Study. We identified 70 cytosine–guanine dinucleotides (CpGs) that mediated 10–73% of the correlation between adversity and depressive symptoms, with DNAm differences at 39 of these CpGs showing protective effects. Our findings suggest DNAm reflects a biological pathway linking childhood adversity to depression and a potential mechanism towards resilience.
UR - http://www.scopus.com/inward/record.url?scp=85218139685&partnerID=8YFLogxK
U2 - 10.1038/s44220-024-00345-8
DO - 10.1038/s44220-024-00345-8
M3 - Article
AN - SCOPUS:85218139685
SN - 2731-6076
VL - 2
SP - 1476
EP - 1485
JO - Nature Mental Health
JF - Nature Mental Health
IS - 12
M1 - 134
ER -